Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Asthma, Bronchial

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Asthma, Bronchial in 2 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Research Excerpts

ExcerptRelevanceReference
"An 18-week ovalbumin challenge period was performed to generate persistent, chronic asthma in BALB/c mice."3.915-HT ( Battaglia, DM; Cormier, SA; Flanagan, TW; Foster, TP; Nichols, CD; Sebastian, MN, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flanagan, TW1
Sebastian, MN1
Battaglia, DM1
Foster, TP1
Cormier, SA2
Nichols, CD2
Nau, F1
Miller, J1
Saravia, J1
Ahlert, T1
Yu, B1
Happel, KI1

Other Studies

2 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Asthma, Bronchial

ArticleYear
5-HT
    Life sciences, 2019, Nov-01, Volume: 236

    Topics: Airway Remodeling; Amphetamines; Animals; Asthma; Chronic Disease; Female; Hypersensitivity; Mice; M

2019
Serotonin 5-HTâ‚‚ receptor activation prevents allergic asthma in a mouse model.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Jan-15, Volume: 308, Issue:2

    Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactiv

2015